Evidence map›Paper›PMID 33077723›Full record

ArticleNature communications2020

Structural basis of heterotetrameric assembly and disease mutations in the human cis-prenyltransferase complex.

Michal Lisnyansky Bar-El, Pavla Vaňková, Adva Yeheskel, Luba Simhaev, Hamutal Engel, Petr Man, Yoni Haitin, Moshe Giladi

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identifying and quantifying membrane interactions of the protein human cis-prenyltransferase.Protein science : a publication of the Protein Society · 2025
    Article
  7. Article
  8. Case Report:Frontiers in pediatrics · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Vertebrate Animal Models of RP59: Current Status and Future Prospects.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Lysosomal cholesterol accumulation contributes to the movement phenotypes associated with NUS1 haploinsufficiency.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Michal Lisnyansky Bar-ElDepartment of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 6997801, Israel.ORCID 0000-0001-6706-1199
Pavla VaňkováInstitute of Microbiology of the Czech Academy of Sciences, Division BioCeV, Prumyslova, 595, 252 50, Vestec, Czech Republic.
Adva YeheskelBlavatnik Center for Drug Discovery, Tel Aviv University, Tel Aviv, 6997801, Israel.
Luba SimhaevBlavatnik Center for Drug Discovery, Tel Aviv University, Tel Aviv, 6997801, Israel.
Hamutal EngelBlavatnik Center for Drug Discovery, Tel Aviv University, Tel Aviv, 6997801, Israel.
Petr ManInstitute of Microbiology of the Czech Academy of Sciences, Division BioCeV, Prumyslova, 595, 252 50, Vestec, Czech Republic.
Yoni HaitinDepartment of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 6997801, Israel. yhaitin@tauex.tau.ac.il.
Moshe GiladiDepartment of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 6997801, Israel. moshegil@post.tau.ac.il.
Tel Aviv University · ILCzech Academy of Sciences · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human cis-prenyltransferase (hcis-PT) is an enzymatic complex essential for protein N-glycosylation. Synthesizing the precursor of the glycosyl carrier dolichol-phosphate, mutations in hcis-PT cause severe human diseases. Here, we reveal that hcis-PT exhibits a heterotetrameric assembly in solution, consisting of two catalytic dehydrodolichyl diphosphate synthase (DHDDS) and inactive Nogo-B receptor (NgBR) heterodimers. Importantly, the 2.3 Å crystal structure reveals that the tetramer assembles via the DHDDS C-termini as a dimer-of-heterodimers. Moreover, the distal C-terminus of NgBR transverses across the interface with DHDDS, directly participating in active-site formation and the functional coupling between the subunits. Finally, we explored the functional consequences of disease mutations clustered around the active-site, and in combination with molecular dynamics simulations, we propose a mechanism for hcis-PT dysfunction in retinitis pigmentosa. Together, our structure of the hcis-PT complex unveils the dolichol synthesis mechanism and its perturbation in disease.

Indexed as

Alkyl and Aryl TransferasesAmino Acid MotifsCatalytic DomainDimerizationHumansMutationReceptors, Cell SurfaceRetinitis PigmentosaTransferasesAlkyl and Aryl Transferasescis-prenyl transferasedehydrodolichyl diphosphate synthetaseNUS1 protein, humanReceptors, Cell SurfaceTransferases

Identifiers

PMID33077723
PMCPMC7573591
OpenAlexW3092916710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.